Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

PURPOSE: Tumor antigen-loaded dendritic cells (DC) are believed to activate antitumor immunity by stimulating T cells, and cytotoxic T lymphocyte-associated antigen 4 (CTLA4)-blocking antibodies should release a key negative regulatory pathway on T cells. The combination was tested in a phase 1 clin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ribas, Antoni, Comin-Anduix, Begoña, Chmielowski, Bartosz, Jalil, Jason, de la Rocha, Pilar, McCannel, Tara A., Ochoa, Maria Teresa, Seja, Elizabeth, Villanueva, Arturo, Oseguera, Denise K., Straatsma, Bradley R., Cochran, Alistair J., Glaspy, John A., Hui, Liu, Marincola, Francesco M., Wang, Ena, Economou, James S., Gomez-Navarro, Jesus
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2765061/
https://ncbi.nlm.nih.gov/pubmed/19789309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-1254
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares